ADOLOR
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid... -induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting mu opioid receptor antagonist, which is considered a back-up compound in its OIC program. The Company has completed Phase 1 clinical evaluation of ADL6906 (beloxepin).
ADOLOR
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
1993-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.adolor.com
Total Employee:
51+
Status:
Active
Contact:
17818601407
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Atlas Therapeutics
Atlas Therapeutics focuses on the discovery, development and commercialization of muscle health and performance therapeutic products.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Insero Health
Insero Health is involved in the discovery, development and commercialization of pharmaceuticals for epilepsy and related conditions.
Kentucky Bioprocessing
Kentucky Bioprocessing is a global leader in the expression, extraction, and commercialization of proteins and other plant-derived products.
Laboratorios Gebro Pharma
Laboratorios Gebro Pharma is focuses on the development and commercialization of treatments against pain and inflammation.
Lucideon
Lucideon is a development and commercialization organization (DCO), specializing in materials technologies and processes
RareGen
RareGen provides strategy, investment, and commercialization for rare disease pharmaceutical products.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
Salient Pharmaceuticals
Salient is developing CASAD™, a proprietary composition proven to adsorb a range of toxins and inflammatory proteins.
ULURU
ULURU engages in the research, development, and commercialization of wound care and mucoadhesive film products.
Current Advisors List
Current Employees Featured
Stock Details
More informations about "Adolor"
About Us - Adolore
While many medical conditions can be a key causal factor for the development of chronic pain, it is now well accepted that for many patients, chronic pain is the disease or pain becomes the …See details»
Leadership Team - adolore
Mr. Barone has extensive experience in the biopharma industry spanning nearly four decades. He was a founding member of Reliant Pharmaceuticals and co-founded Essential …See details»
Adolor - LinkedIn
Adolor Corporation (NASDAQ:ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products.See details»
Adolor - Crunchbase Company Profile & Funding
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain …See details»
Adolore Biotherapeutics - Crunchbase Company Profile & Funding
Organization. Adolore Biotherapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Adolore Biotherapeutics is a health company …See details»
Adolore Biotherapeutics - LinkedIn
Adolore Biotherapeutics, Inc., is a biotechnology company focused on developing novel therapies for the treatment of chronic pain and other pain and nervous system conditions or disorders.See details»
Adolore Biotherapeutics Strengthens Management Team and …
Jan 17, 2023 / Adolore Biotherapeutics, Inc. ("Adolore" or the "Company"), a biotechnology company focused on developing breakthrough opioid-free pain relieving (analgesic) treatments …See details»
Adolore Biotherapeutics to Present at the Virtual Investor 2023 ...
Jan 18, 2023 / Adolore Biotherapeutics, Inc. ("Adolore" or the "Company") a biotechnology company focused on developing breakthrough opioid-free pain relieving (analgesic) treatments …See details»
Adolore Biotherapeutics - PitchBook
Adolore Biotherapeutics General Information Description. Developer of gene therapy biotechnology designed for chronic pain treatment. The company offers long-acting, locally …See details»
Adolore Biotherapeutics, Inc. - VentureRadar
Adolore Biotherapeutics, Inc. is a new biotechnology company focused on developing breakthrough opioid-free pain relieving (analgesic) treatments for chronic pain. Our founders …See details»
Board of Directors - adolore
Dr. Rogers brings a deep biotech executive perspective to Adolore. Before founding his current venture Gibson Oncology, Dr. Rogers’ track record includes founder and chairman of PolaRX …See details»
Adolore BioTherapeutics Outlines Strategy for its Next Generation ...
May 21, 2024 Adolore BioTherapeutics, Inc., is a biotechnology company focused on developing novel therapies for the treatment of chronic pain and other pain and nervous system conditions …See details»
Adolore Biotherapeutics Enters into Exclusive License ... - BioSpace
May 23, 2023 Adolore Biotherapeutics, Inc., is a biotechnology company focused on developing novel therapies for the treatment of chronic pain and other pain and nervous system conditions …See details»
Adolore Biotherapeutics Announces Launch of Social Media …
Jun 27, 2023 Adolore Biotherapeutics, Inc. ("Adolore" or the "Company") a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for pain, …See details»
Adolore Biotherapeutics - Contacts, Employees, Board Members, …
Adolore Biotherapeutics is a health company that develops disease-modifying non-opoid analgesic gene therapy for eating chronic pain. Search Crunchbase. Start Free Trial . Chrome …See details»
Adolore Biotherapeutics Strengthens Management Team and …
Jan 17, 2023 Mr. Rongen appointed as CEO and member of the Board bringing 30 years of executive leadership experience and expertise across a number of therapeutic areas …See details»
Adolore BioTherapeutics Outlines Strategy for its Next Generation ...
May 21, 2024 Adolore's highly differentiated approach to treating chronic pain is based on two key innovative aspects: CA8* is a novel therapeutic protein that has the potential to benefit …See details»
ADB-102 - Drug Targets, Indications, Patents - Synapse - Patsnap
About Adolore BioTherapeutics, Inc. Adolore BioTherapeutics, Inc., is a biotechnology company focused on developing novel therapies for treating chronic pain using a revolutionary intra …See details»
Our Pipeline - adolore
Stay up to date and get notifications via email when we post updatesSee details»